Generation of high cross-presentation ability human dendritic cells by combination of interleukin 4, interferon β and GM-CSF

Dendritic cell (DC)-based immunotherapies have been utilized for the treatment of numerous diseases. However, the conventional generation strategies of DCs in vitro require 7 days and these DCs showed an unsatisfactory function, which prompted us to explore new approaches. We found that in vitro cul...

Descripción completa

Detalles Bibliográficos
Autores principales: Pi, Yihua, Li, Yifang, Liang, Rongyi, Xiao, Jian, Leng, Jing, Zhang, Lifeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2022
Materias:
Experimental Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9894086/
https://www.ncbi.nlm.nih.gov/pubmed/36751394
http://dx.doi.org/10.5114/ceji.2022.117767

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9894086/
https://www.ncbi.nlm.nih.gov/pubmed/36751394
http://dx.doi.org/10.5114/ceji.2022.117767

Ejemplares similares